BioHarvest Sciences Inc.

Research BioHarvest Sciences Inc. (BHST) on Bullrun: market cap USD 41.94M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 41.94M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 34.51M-USD 11.14M-USD 9.58M59.3%-0.6USD 23.03MUSD 14.10MUSD 25.45M
FY2024USD 25.19M-USD 12.91M-USD 9.52M55.4%-0.8USD 2.39MUSD 13.82MUSD 1.33M
FY2023USD 12.67M-USD 12.56M-USD 10.00M44.5%-0.93USD 5.36MUSD 22.34M-USD 14.85M
FY2022USD 5.50M-USD 11.24M-USD 10.50M22.2%-0.7USD 1.74MUSD 10.56M-USD 5.93M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-16USD 41.94Mn/an/an/a
20252025-12-31USD 117.64Mn/an/an/a
20242024-12-31USD 107.09Mn/an/an/a
20232023-12-29USD 2.16Mn/an/an/a
20222022-12-30USD 2.87Mn/an/an/a
20212021-12-31USD 4.67Mn/an/an/a

About BioHarvest Sciences Inc.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients.

Related stock research

Other Consumer Defensive stocks

Frequently asked questions

What is BioHarvest Sciences Inc.'s market cap?

BioHarvest Sciences Inc.'s market capitalization is USD 41.94M.

What does BioHarvest Sciences Inc. do?

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients.